From here, they are now going into combo trial with Tecentriq. Tecentrig is an approved FDA drug. I wonder if the PH1b trial should show high efficacy, can Roche then apply to FDA for fast track to market of this PD1vaxx/Tecentriq treatment? Or must they go to PH2 first?
Ann: IMUGENE ANNOUNCES PUBLICATION OF ASCO 2022 PD1-VAXX ABSTRACT, page-42
-
- There are more pages in this discussion • 74 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.4¢ |
Change
0.001(2.33%) |
Mkt cap ! $323.5M | |||
| Open | High | Low | Value | Volume |
| 4.3¢ | 4.4¢ | 4.3¢ | $250.2K | 5.801M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 2297105 | 4.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.4¢ | 2153861 | 15 |
View Market Depth
| Last trade - 11.27am 01/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |